New medication approved for drug-resistant HIV - wave3.com-Louisville News, Weather & Sports

New medication approved for drug-resistant HIV

  • HealthMore>>

  • The creator of Internet Explorer wants to read your mind with a bracelet

    The creator of Internet Explorer wants to read your mind with a bracelet

    Thursday, June 21 2018 5:15 PM EDT2018-06-21 21:15:03 GMT
    The idea of controlling a computer with your thoughts sounds amazing. A New York startup called CRTL-Labs has created a non-invasive device they claim will make this an everyday reality.More >>
    The idea of controlling a computer with your thoughts sounds amazing. A New York startup called CRTL-Labs has created a non-invasive device they claim will make this an everyday reality.More >>
  • The time is right to take advantage of these Apple Watch deals for May 2018

    The time is right to take advantage of these Apple Watch deals for May 2018

    Tuesday, May 1 2018 8:05 AM EDT2018-05-01 12:05:09 GMT
    The Apple Watch has surged to prominence in recent years. If you're in the market for an iOS wearable, we've sniffed out the best Apple Watch deals available right now for all three models of this great smartwatch.More >>
    The Apple Watch has surged to prominence in recent years. If you're in the market for an iOS wearable, we've sniffed out the best Apple Watch deals available right now for all three models of this great smartwatch.More >>
  • The best fitness trackers

    The best fitness trackers

    Saturday, May 5 2018 8:20 AM EDT2018-05-05 12:20:24 GMT
    Looking for your first fitness tracker, or an upgrade to the one you're already wearing? There are plenty of the wrist-worn gadgets available from companies like Garmin, Apple, and Fitbit but it's hard to know...More >>
    Looking for your first fitness tracker, or an upgrade to the one you're already wearing? There are plenty of the wrist-worn gadgets available from companies like Garmin, Apple, and Fitbit but it's hard to know which are...More >>

(HealthDay News) -- Trogarzo (ibalizumab-uiyk) has been approved by the U.S. Food and Drug Administration to treat AIDS-causing HIV that has not responded to other antiretroviral medications.

Trogarzo is given intravenously once every 14 days in combination with other antiretroviral drugs, the FDA said Tuesday in a news release.

"While most patients living with HIV can be successfully treated using a combination of two or more antiretroviral drugs, a small percentage of patients who have taken many HIV drugs in the past have multidrug resistant HIV, limiting their treatment options," said Dr. Jeff Murray, deputy director of the agency's Division of Antiviral Products.

"Trogarzo is the first drug in a new class of antiretroviral medications that can provide significant benefit to patients who have run out of HIV treatment options," Murray added.

Trogarzo was evaluated in clinical studies involving 40 people who continued to have high blood levels of HIV, despite use of antiretroviral drugs. After 24 weeks of Trogarzo and other drugs, 43 percent of trial participants achieved HIV suppression, the FDA said.

The most common adverse reactions to Trogarzo were diarrhea, dizziness, nausea and rash. More severe side effects included immune system abnormalities.

Trogarzo is produced by TaiMed Biologics, based in Taiwan.

More information

Visit the FDA to learn more about Trogarzo.

Copyright © 2018 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by Frankly